C. Peterson

1.9k total citations
46 papers, 1.6k citations indexed

About

C. Peterson is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, C. Peterson has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Public Health, Environmental and Occupational Health and 12 papers in Hematology. Recurrent topics in C. Peterson's work include Acute Lymphoblastic Leukemia research (12 papers), Nausea and vomiting management (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). C. Peterson is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Nausea and vomiting management (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). C. Peterson collaborates with scholars based in Sweden, United States and Denmark. C. Peterson's co-authors include Gösta Gahrton, Sigurd Vitols, Astrid Gruber, Åke Öst, Dawei Xu, Pavel Pisa, Michèle Masquelier, Magnus Björkholm, Gunnar Steineck and A. Trouet and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

C. Peterson

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Peterson Sweden 22 539 426 320 302 274 46 1.6k
Sophie Doublier Italy 28 797 1.5× 267 0.6× 227 0.7× 253 0.8× 103 0.4× 46 2.3k
Detlef Lang Germany 21 462 0.9× 337 0.8× 150 0.5× 75 0.2× 95 0.3× 40 1.5k
W J Nooijen Netherlands 19 528 1.0× 1.3k 3.0× 124 0.4× 187 0.6× 154 0.6× 29 1.9k
Carlo Rumi Italy 26 693 1.3× 430 1.0× 138 0.4× 105 0.3× 145 0.5× 103 2.3k
Paola Ferrari Italy 28 957 1.8× 837 2.0× 219 0.7× 496 1.6× 223 0.8× 103 2.6k
Duane A. Tewksbury United States 21 742 1.4× 304 0.7× 117 0.4× 129 0.4× 106 0.4× 47 2.2k
Jer-Yuarn Wu Taiwan 19 663 1.2× 151 0.4× 303 0.9× 134 0.4× 53 0.2× 43 2.4k
Yoshiro Kobayashi Japan 23 707 1.3× 197 0.5× 182 0.6× 87 0.3× 121 0.4× 102 1.9k
Taher Nassar Israel 27 508 0.9× 205 0.5× 108 0.3× 250 0.8× 59 0.2× 51 1.9k
Thomas Schöndorf Germany 21 590 1.1× 341 0.8× 126 0.4× 145 0.5× 120 0.4× 71 1.4k

Countries citing papers authored by C. Peterson

Since Specialization
Citations

This map shows the geographic impact of C. Peterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Peterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Peterson more than expected).

Fields of papers citing papers by C. Peterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Peterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Peterson. The network helps show where C. Peterson may publish in the future.

Co-authorship network of co-authors of C. Peterson

This figure shows the co-authorship network connecting the top 25 collaborators of C. Peterson. A scholar is included among the top collaborators of C. Peterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Peterson. C. Peterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gréen, Henrik, Ib Jarle Christensen, Kim Dalhoff, et al.. (2015). Polymorphisms in the ABCB1 gene and effect on outcome and toxicity in childhood acute lymphoblastic leukemia. The Pharmacogenomics Journal. 15(4). 372–379. 76 indexed citations
2.
Bergmann, Troels K., Charlotte Brasch‐Andersen, Henrik Gréen, et al.. (2010). Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer. The Pharmacogenomics Journal. 11(2). 113–120. 78 indexed citations
3.
Vikingsson, Svante, Björn Carlsson, Sven Almér, & C. Peterson. (2010). How Should Thiopurine Treatment be Monitored?— Methodological Aspects. Nucleosides Nucleotides & Nucleic Acids. 29(4-6). 278–283. 5 indexed citations
4.
Fotoohi, Alan, M. Lindqvist, C. Peterson, & Freidoun Albertioni. (2006). Impaired Transport as a Mechanism of Resistance to Thiopurines in Human T-Lymphoblastic Leukemia Cells. Nucleosides Nucleotides & Nucleic Acids. 25(9-11). 1039–1044. 2 indexed citations
5.
Lindqvist, M., Ulf Hindorf, Sven Almér, et al.. (2006). No Induction of Thiopurine Methyltransferase During Thiopurine Treatment in Inflammatory Bowel Disease. Nucleosides Nucleotides & Nucleic Acids. 25(9-11). 1033–1037. 13 indexed citations
6.
Xu, Dawei, Astrid Gruber, Magnus Björkholm, C. Peterson, & Pavel Pisa. (1999). Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. British Journal of Cancer. 80(8). 1156–1161. 75 indexed citations
7.
Börjeson, Sussanne, et al.. (1996). Impact of tumour burden on chemotherapy-induced nausea and vomiting. British Journal of Cancer. 74(7). 1114–1119. 10 indexed citations
8.
Eksborg, Staffan, Freidoun Albertioni, Charlotte Ulrikka Rask, et al.. (1996). Methotrexate plasma pharmacokinetics: importance of assay method. Cancer Letters. 108(2). 163–169. 17 indexed citations
9.
Albertioni, Freidoun, Olof Beck, C. Peterson, et al.. (1995). Methotrexate in juvenile rheumatoid arthritis. European Journal of Clinical Pharmacology. 47(6). 507–11. 41 indexed citations
10.
Fredrikson, M, et al.. (1994). Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline. British Journal of Cancer. 70(4). 642–645. 22 indexed citations
11.
Fredrikson, Mats, et al.. (1993). Endogenous cortisol exerts antiemetic effect similar to that of exogenous corticosteroids. British Journal of Cancer. 68(1). 112–114. 32 indexed citations
12.
Fredrikson, M, et al.. (1992). Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. British Journal of Cancer. 65(5). 779–780. 81 indexed citations
13.
Gruber, Astrid, Sigurd Vitols, Svante Norgren, et al.. (1992). Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia. British Journal of Cancer. 66(2). 266–272. 52 indexed citations
14.
Nygren, Peter, Rolf Larsson, Astrid Gruber, C. Peterson, & Jonas Bergh. (1991). Doxorubicin selected multidrug-resistant small cell lung cancer cell lines characterised by elevated cytoplasmic Ca2+ and resistance modulation by verapamil in absence of P-glycoprotein overexpression. British Journal of Cancer. 64(6). 1011–1018. 32 indexed citations
15.
Lafolie, Pierre, et al.. (1991). Intraindividual variation in 6-mercaptopurine pharmacokinetics during oral maintenance therapy of children with acute lymphoblastic leukaemia. European Journal of Clinical Pharmacology. 40(6). 599–601. 21 indexed citations
16.
Steineck, Gunnar, et al.. (1991). Effects of Ondansetron on Chemotherapy-induced Acute and Delayed Emesis—A Pilot Study. Acta Oncologica. 30(5). 649–651. 3 indexed citations
17.
18.
Liliemark, Jan, et al.. (1990). On the paradoxically concentration-dependent metabolism of 6-mercaptopurine in WEHI-3b murine leukemia cells.. PubMed. 50(1). 108–12. 20 indexed citations
19.
Mouridsen, H.T., Lars Bastholt, Jonas Bergh, et al.. (1990). Current Status of Epirubicin (Farmorubicin) in the Treatment of Solid Tumours. Acta Oncologica. 29(3). 257–285. 45 indexed citations
20.
Thornton, Janice E., et al.. (1989). Different roles of alpha-noradrenergic receptor subtypes in regulating lordosis. Pharmacology Biochemistry and Behavior. 34(1). 89–93. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophie Doublier Breakdown of academic impact, for papers by Detlef Lang Breakdown of academic impact, for papers by W J Nooijen Breakdown of academic impact, for papers by Carlo Rumi Breakdown of academic impact, for papers by Paola Ferrari Breakdown of academic impact, for papers by Duane A. Tewksbury Breakdown of academic impact, for papers by Jer-Yuarn Wu Breakdown of academic impact, for papers by Yoshiro Kobayashi Breakdown of academic impact, for papers by Taher Nassar Breakdown of academic impact, for papers by Thomas Schöndorf
Rankless by CCL
2026